查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614210

腸道疾病檢測市場：按產品、疾病類型、診斷技術、檢測地點 - 全球預測 2025-2030

Enteric Disease Testing Market by Product (Consumables, Kits, Reagents), Disease Type (Bacterial, Parasitic, Viral), Diagnostic Techniques, Testing Site - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年腸道疾病檢測市場價值為43.1億美元，預計到2024年將達到45.4億美元，複合年成長率為5.47%，到2030年預計將達到62.6億美元。

腸道疾病檢測的範圍包括識別由病毒、細菌和寄生蟲引起的胃腸道感染疾病的診斷方法。這種檢測對於公共衛生監測和臨床管理都至關重要，可以及時介入以控制疫情並確保適當的治療。應用範圍廣泛，包括診斷實驗室、醫院、診所、公共衛生組織等。最終用途領域包括從專注於患者護理的醫療設施到開發先進診斷工具的研究機構。

主要市場統計
基準年[2023] 43.1億美元
預計年份 [2024] 45.4億美元
預測年份 [2030] 62.6億美元
複合年成長率（%） 5.47%

市場成長受到全球旅行者數量增加和氣候變遷導致腸道疾病發病率增加等因素的顯著影響，氣候變遷影響病原體的分佈。分子診斷技術的進步以及人們對感染疾病早期檢測和管理重要性的認知不斷提高，增加了對快速、準確診斷方法的需求。機會比比皆是，包括非侵入性檢測的創新和就地檢驗套件的開發，以到達缺乏傳統檢測基礎設施的偏遠和資源匱乏的環境。

然而，市場面臨局限性，特別是在新興市場，包括與先進診斷技術相關的高成本以及缺乏操作先進設備的熟練人員。監管障礙也減緩了新測試解決方案的採用。諸如需要對新測試進行廣泛驗證和病原體的可變代表性等挑戰使標準化工作變得更加複雜。

創新應著重於提高測試靈敏度和特異性，同時降低成本並提高可近性。可以在一次測試中檢測多種病原體的多重檢測的研究特別有前景。此外，開發攜帶式且易於使用的設備用於疫情爆發情況下的現場測試可以擴大市場開拓。

這是一個競爭激烈但充滿活力的市場，由持續的研究和技術進步所定義，這些研究和技術進步有望推動進一步成長，同時解決當前的挑戰。策略夥伴關係、併購以及專注於開發具有成本效益的解決方案，對於在不斷變化的環境中實現業務擴張至關重要。

市場動態：揭示快速發展的腸道疾病檢測市場的關鍵市場洞察

腸道疾病檢測市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 由於衛生條件差和供水受污染，腸道疾病盛行率不斷上升
    • 診斷測試的創新描述了更高的靈敏度、特異性和更快的結果
    • 政府和非政府組織為對抗感染疾病所做的努力
  • 市場限制因素
    • 新興國家先進測試成本上升且基礎設施缺乏
  • 市場機會
    • 加大醫療基礎建設投資，注重預防診斷
    • 研發活動和市場拓展的策略聯盟和合作關係
  • 市場問題
    • 產品核准和商業化規定

波特五力：開拓腸道疾病檢測市場的策略工具

波特五力：框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解腸道疾病檢測市場的外部影響

外部宏觀環境因素對腸道疾病檢測市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解腸道疾病檢測市場的競爭格局

對腸道疾病檢測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：腸道疾病檢測市場供應商績效評估

FPNV定位矩陣是評估腸道疾病檢測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製腸道疾病檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對腸道疾病檢測市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於衛生條件不佳和水污染導致腸道疾病傳播
      • 診斷測試的技術創新提高了靈敏度、特異性，並更快地得出結果。
      • 政府和非政府組織為對抗感染疾病所做的努力
    • 抑制因素
      • 新興國家先進測試高成本且基礎設施缺乏
    • 機會
      • 增加對衛生基礎設施的投資並專注於預防性診斷
      • 研發活動和市場拓展的策略夥伴關係和合作
    • 任務
      • 產品核准和商業化規定
  • 市場區隔分析
    • 疾病類型：在細菌檢測中更多地採用多重和分子診斷方法
    • 檢測地點：快速診斷對於醫院即時患者照護至關重要
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章腸道疾病檢測市場：依產品

  • 介紹
  • 消耗品
  • 套件
  • 試劑

第7章腸道疾病檢測市場：依疾病類型

  • 介紹
  • 細菌
    • 霍亂
    • 大腸桿菌
    • 沙門氏菌病
  • 寄生蟲
  • 病毒

第8章腸道疾病檢測市場：透過診斷技術

  • 介紹
  • 免疫檢測
  • 分子診斷
    • PCR
    • 即時PCR
  • 快速診斷
    • 量油尺
    • 橫向流動化驗

第9章腸道疾病檢測市場：依檢測地點

  • 介紹
  • 醫院內部
  • 照護現場
  • 獨立實驗室

第10章美洲腸道疾病檢驗市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太腸道疾病檢驗市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲腸道疾病檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • FDA核准MeMed BV Direct 從全血中提取
    • Avacta 收購歐洲診斷測試製造商
    • 默克透過收購 Prometheus Biosciences, Inc. 加強了免疫學產品線。
  • 戰略分析和建議

公司名單

  • 3M Company
  • Abbott Laboratories
  • Als Limited
  • Asure Quality
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerica Inc.
  • bioMerieux SA
  • Bureau Veritas Group
  • Cepheid Inc.
  • Coris BioConcept SPRL
  • DiaSorin
  • Eurofins Scientific SE
  • Hardy Diagnostics
  • Intertek Group PLC
  • Merck & Co., Inc.
  • Merck KGAA
  • Meridian Bioscience Inc.
  • Merieux NutriSciences Corporation
  • Neogen Corporation
  • Nova Biologicals
  • Perkinelmer, Inc.
  • Qiagen NV
  • Quest Diagnostics
  • Romer Labs Division Holding GmbH
  • SGS SA
  • Symbio Laboratories
  • Thermo Fisher Scientific Inc.
  • Trinity BIoTech PLC
  • TUV SUD AG
Product Code: MRR-732E7CFCB4A5

The Enteric Disease Testing Market was valued at USD 4.31 billion in 2023, expected to reach USD 4.54 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 6.26 billion by 2030.

The scope of enteric disease testing encompasses diagnostic methods used to identify infections within the gastrointestinal tract caused by viruses, bacteria, and parasites. This testing is crucial for both public health surveillance and clinical management, enabling timely interventions to control outbreaks and ensure appropriate medical treatment. Applications are widespread and include diagnostic labs, hospitals, clinics, and public health organizations. End-use sectors range from healthcare facilities focusing on patient care to research institutions developing advanced diagnostic tools.

KEY MARKET STATISTICS
Base Year [2023] USD 4.31 billion
Estimated Year [2024] USD 4.54 billion
Forecast Year [2030] USD 6.26 billion
CAGR (%) 5.47%

Market growth is significantly influenced by factors such as rising incidence of enteric diseases due to more global travel and changes in climate, which affect pathogen distribution. The demand for rapid, accurate diagnostic methods is increasing, driven by technological advancements in molecular diagnostics and the rising awareness about the importance of early detection and management of infections. Opportunities abound in the innovation of non-invasive testing methods and the development of point-of-care testing kits, which cater to remote or resource-poor settings where traditional lab infrastructure may be lacking.

However, the market faces limitations, including high costs associated with advanced diagnostic technologies and a lack of skilled personnel to operate sophisticated equipment, particularly in developing regions. Regulatory hurdles can also slow the introduction of new testing solutions. Challenges such as the need for extensive validation of novel tests and the variability in pathogen presentation complicate standardization efforts.

Innovation should focus on enhancing the sensitivity and specificity of tests while reducing costs and improving accessibility. Research into multiplex assays capable of detecting multiple pathogens in a single test is particularly promising. Additionally, developing portable, easy-to-use devices for field testing in outbreak scenarios can broaden market reach.

The market is competitive but dynamic, defined by ongoing research and technological progress that promises to address current challenges while driving further growth. Strategic partnerships, mergers, and acquisitions, along with a focus on developing cost-efficient solutions, will be crucial for business expansion in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enteric Disease Testing Market

The Enteric Disease Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
    • Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
    • Governmental and non-governmental organizations' initiatives to control infectious diseases
  • Market Restraints
    • High cost of advanced tests and the lack of infrastructure in emerging countries
  • Market Opportunities
    • Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
    • Strategic partnerships and collaborations for R&D activities and market expansion
  • Market Challenges
    • Regulations concerning the approval and commercialization of product

Porter's Five Forces: A Strategic Tool for Navigating the Enteric Disease Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enteric Disease Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enteric Disease Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enteric Disease Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enteric Disease Testing Market

A detailed market share analysis in the Enteric Disease Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enteric Disease Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enteric Disease Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enteric Disease Testing Market

A strategic analysis of the Enteric Disease Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Als Limited, Asure Quality, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerica Inc., bioMerieux SA, Bureau Veritas Group, Cepheid Inc., Coris BioConcept SPRL, DiaSorin, Eurofins Scientific SE, Hardy Diagnostics, Intertek Group PLC, Merck & Co., Inc., Merck KGAA, Meridian Bioscience Inc., Merieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Qiagen N.V., Quest Diagnostics, Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and TUV SUD AG.

Market Segmentation & Coverage

This research report categorizes the Enteric Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Kits, and Reagents.
  • Based on Disease Type, market is studied across Bacterial, Parasitic, and Viral. The Bacterial is further studied across Cholera, Escherichia coli, and Salmonellosis.
  • Based on Diagnostic Techniques, market is studied across Immunoassays, Molecular Diagnostics, and Rapid Diagnostics. The Molecular Diagnostics is further studied across PCR and Real-time PCR. The Rapid Diagnostics is further studied across Dipsticks and Lateral Flow Assays.
  • Based on Testing Site, market is studied across In-Hospital, Point-of-Care, and Standalone Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
      • 5.1.1.2. Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
      • 5.1.1.3. Governmental and non-governmental organizations' initiatives to control infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced tests and the lack of infrastructure in emerging countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
      • 5.1.3.2. Strategic partnerships and collaborations for R&D activities and market expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Regulations concerning the approval and commercialization of product
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
    • 5.2.2. Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Enteric Disease Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Kits
  • 6.4. Reagents

7. Enteric Disease Testing Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Bacterial
    • 7.2.1. Cholera
    • 7.2.2. Escherichia coli
    • 7.2.3. Salmonellosis
  • 7.3. Parasitic
  • 7.4. Viral

8. Enteric Disease Testing Market, by Diagnostic Techniques

  • 8.1. Introduction
  • 8.2. Immunoassays
  • 8.3. Molecular Diagnostics
    • 8.3.1. PCR
    • 8.3.2. Real-time PCR
  • 8.4. Rapid Diagnostics
    • 8.4.1. Dipsticks
    • 8.4.2. Lateral Flow Assays

9. Enteric Disease Testing Market, by Testing Site

  • 9.1. Introduction
  • 9.2. In-Hospital
  • 9.3. Point-of-Care
  • 9.4. Standalone Laboratories

10. Americas Enteric Disease Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Enteric Disease Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Enteric Disease Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA Clears MeMed BV Direct from Whole Blood
    • 13.3.2. Avacta Acquires European Diagnostic Test Maker
    • 13.3.3. Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Als Limited
  • 4. Asure Quality
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Biomerica Inc.
  • 8. bioMerieux SA
  • 9. Bureau Veritas Group
  • 10. Cepheid Inc.
  • 11. Coris BioConcept SPRL
  • 12. DiaSorin
  • 13. Eurofins Scientific SE
  • 14. Hardy Diagnostics
  • 15. Intertek Group PLC
  • 16. Merck & Co., Inc.
  • 17. Merck KGAA
  • 18. Meridian Bioscience Inc.
  • 19. Merieux NutriSciences Corporation
  • 20. Neogen Corporation
  • 21. Nova Biologicals
  • 22. Perkinelmer, Inc.
  • 23. Qiagen N.V.
  • 24. Quest Diagnostics
  • 25. Romer Labs Division Holding GmbH
  • 26. SGS SA
  • 27. Symbio Laboratories
  • 28. Thermo Fisher Scientific Inc.
  • 29. Trinity Biotech PLC
  • 30. TUV SUD AG

LIST OF FIGURES

  • FIGURE 1. ENTERIC DISEASE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENTERIC DISEASE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENTERIC DISEASE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENTERIC DISEASE TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHOLERA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIPSTICKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
  • TABLE 324. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 325. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023